Clinical trials: Stroke, Acute Cerebral Infarction

Influenza, Pneumonia

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

• Completed
• Age: 18 to 64 years
• Observational study
• Vaccines
• Results posted

The overall objective of this study is to describe the effectiveness of Flublok Quadrivalent vaccine compared to standard dose inactivated influenza vaccine (SD-IIV) in adults 18 through 64 years of age.

Conditions

Influenza, Pneumonia, Lower Respiratory Tract Infection, Acute Myocardial Infarction

Trial name

NCT03694392

Testing

Flublok Quadrivalent, Standard Dose Inactivated Influenza Vaccine (SD-IIV)

Where

United States

Volunteers

2,776,278 people, healthy volunteers welcome

Sponsor

Kaiser Permanente